MoneyWorks4Me

The sales figure stood at Rs. 1424.93 millions for the March 2024 quarter. The mentioned figure indicates a growth of about 26.71% as compared to Rs. 1124.60 millions during the year-ago period.Good  Net Profit growth of 48.03% reported above the corresponding previous quarter figure of Rs. 125.63 millions to Rs. 185.97 millioins.OP of the company witnessed a marginal growth to 254.02 millions from 205.43 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1424.93 1124.60 26.71 5805.50 5103.09 13.76 5805.50 5103.09 13.76
Other Income 70.19 39.46 77.88 344.22 224.84 53.10 344.22 224.84 53.10
PBIDT 254.02 205.43 23.65 1343.30 1116.50 20.31 1343.30 1116.50 20.31
Interest 4.99 11.48 -56.53 14.63 20.29 -27.90 14.63 20.29 -27.90
PBDT 249.03 193.95 28.40 1328.67 1096.21 21.21 1328.67 1096.21 21.21
Depreciation 26.86 24.13 11.31 106.25 91.66 15.92 106.25 91.66 15.92
PBT 222.17 169.82 30.83 1222.42 1004.55 21.69 1222.42 1004.55 21.69
TAX 36.20 44.19 -18.08 289.38 275.56 5.02 289.38 275.56 5.02
Deferred Tax -4.93 10.11 -148.76 34.95 15.86 120.37 34.95 15.86 120.37
PAT 185.97 125.63 48.03 933.04 728.99 27.99 933.04 728.99 27.99
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 17.83 18.27 -2.41 23.14 21.88 5.76 23.14 21.88 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..